SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Adding quetiapine to SRI in treatment-resistant obsessive???compulsive disorder: a randomized controlled treatment study
10 references·16 citing·41 second hop
Adding quetiapine to SRI in treatment-resistant obsessive???compulsive disorder: a randomized controlled treatment study (2005)Adding quetiapine to SRI in treatment-res…Evidence-based pharmacotherapy of obsessive-compulsive disorder (2012)Evidence-based pharmacotherap…Evidence-based pharmacotherapy of obsessive–compulsive disorder (2005)Evidence-based pharmacotherap…Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine (2004)Augmentation of Serotonin Reu…A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder (2004)A double-blind, placebo-contr…Risperidone augmentation in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study (2003)Risperidone augmentation in t…Treatment non-response in OCD: methodological issues and operational definitions (2002)Treatment non-response in OCD…Quetiapine augmentation in patients with treatment resistant obsessive???compulsive disorder: a single-blind, placebo-controlled study (2002)Quetiapine augmentation in pa…A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder (2000)A Double-blind, Placebo-Contr…The Yale Global Tic Severity Scale: Initial Testing of a Clinician-Rated Scale of Tic Severity (1989)The Yale Global Tic Severity …A New Depression Scale Designed to be Sensitive to Change (1979)A New Depression Scale Design…A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy (2017)A Systematic Review of Eviden…Obsessive–Compulsive Disorder (2014)Obsessive–Compulsive DisorderCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014)Canadian clinical practice gu…Augmentation strategies in obsessive–compulsive disorder (2013)Augmentation strategies in ob…Translational approaches to obsessive‐compulsive disorder: from animal models to clinical treatment (2011)Translational approaches to o…A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder (2011)A Double-Blind, Randomized, C…Second-generation antipsychotics for obsessive compulsive disorder (2010)Second-generation antipsychot…Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review (2009)Probing Compulsive and Impuls…Duration of Untreated Illness as a Predictor of Treatment Response and Remission in Obsessive–Compulsive Disorder (2009)Duration of Untreated Illness…Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a 12-week open-label preliminary study (2009)Aripiprazole augmentation of …World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)World Federation of Societies…Review: A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD) (2008)Review: A psychopharmacologic…Quetiapine Addition to Serotonin Reuptake Inhibitors in Patients With Severe Obsessive-Compulsive Disorder (2008)Quetiapine Addition to Seroto…8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder (2008)8-week, single-blind, randomi…Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive???compulsive disorder: a meta-analysis of randomized controlled treatment trials (2006)Adjunctive quetiapine for ser…A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder (2006)A systematic review: antipsyc…Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Diagnostic and Statistical Manual of Mental Disorders (2013)Epidemiology of anxiety disorders in the 21st century (2015)Treatment of anxiety disorders (2017)Obsessive–compulsive disorder (2019)The Global Assessment Scale (1976)Intraclass correlations: Uses in assessing rater reliability. (1979)Manual for the Child: Behavior Checklist and Revised Child Behavior Profile (1983)Tourette syndrome, associated conditions and the complexities of treatment (2000)Behavior Therapy for Children With Tourette Disorder (2010)The Epidemiology of Major Depressive Disorder (2003)Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Anxiety disorders (2017)Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials (2017)Anxiety Disorders (2022)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Bias in meta-analysis detected by a simple, graphical test (1997)The Cochrane Library (2005)Obsessive-compulsive disorder (2009)Symptoms of obsessive-compulsive disorder (1997)Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases (1998)Use of Factor-Analyzed Symptom Dimensions to Predict Outcome With Serotonin Reuptake Inhibitors and Placebo in the Treatment of Obsessive-Compulsive Disorder (1999)Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive‐compulsive disorder (2016)A RATING SCALE FOR DEPRESSION (1960)The Yale-Brown Obsessive Compulsive Scale (1989)Cochrane Database of Systematic Reviews (2008)Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology (2014)Development of a Rating Scale for Primary Depressive Illness (1967)Diagnostic Criteria for Use in Psychiatric Research (1972)The PHQ-9 (2001)The PHQ-9: A New Depression Diagnostic and Severity Measure (2002)The validity of the Hospital Anxiety and Depression Scale (2002)Local Cerebral Glucose Metabolic Rates in Obsessive-Compulsive Disorder (1987)The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers (2005)Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited (2007)Introduction to Behavioral Addictions (2010)Research Review: What we have learned about the causes of eating disorders – a synthesis of sociocultural, psychological, and biological research (2015)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)ECDEU Assessment Manual for Psychopharmacology (1976)Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2008)
this work references cited by second hop

References

  • 1979A New Depression Scale Designed to be Sensitive to Change13,964 cited
  • 1989The Yale Global Tic Severity Scale: Initial Testing of a Clinician-Rated Scale of Tic Severity2,183 cited
  • 2000A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder571 cited
  • 2002Treatment non-response in OCD: methodological issues and operational definitions416 cited
  • 2012Evidence-based pharmacotherapy of obsessive-compulsive disorder336 cited
  • 2004Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine220 cited
  • 2005Evidence-based pharmacotherapy of obsessive–compulsive disorder213 cited
  • 2003Risperidone augmentation in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study197 cited
  • 2004A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder155 cited
  • 2002Quetiapine augmentation in patients with treatment resistant obsessive???compulsive disorder: a single-blind, placebo-controlled study149 cited

Cited by

  • 2014Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders1,092 cited
  • 2008World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision862 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2009Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review698 cited
  • 2006A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder637 cited
  • 2006Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive???compulsive disorder: a meta-analysis of randomized controlled treatment trials103 cited
  • 2010Second-generation antipsychotics for obsessive compulsive disorder96 cited
  • 2009Duration of Untreated Illness as a Predictor of Treatment Response and Remission in Obsessive–Compulsive Disorder96 cited
  • 20088-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder92 cited
  • 2017A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy90 cited
  • 2011Translational approaches to obsessive‐compulsive disorder: from animal models to clinical treatment82 cited
  • 2014Obsessive–Compulsive Disorder79 cited
  • 2008Quetiapine Addition to Serotonin Reuptake Inhibitors in Patients With Severe Obsessive-Compulsive Disorder78 cited
  • 2013Augmentation strategies in obsessive–compulsive disorder75 cited
  • 2011A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder73 cited
  • 2009Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a 12-week open-label preliminary study71 cited
  • 2008Review: A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)63 cited